...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection
【24h】

Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection

机译:在前列腺癌放射治疗中,谁将从水凝胶直肠垫片植入术中受益最大?基于模型的患者选择方法

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: Previous studies confirmed that implantable rectum spacers (IRS) decreased acute gastro-intestinal (GI) toxicity in a significant percentage of prostate cancer patients undergoing intensity modulated radiation therapy (IMRT). We developed decision rules based on clinical risk factors (CRFs) to select those patients who are expected to benefit most from IRS implantation.
机译:背景与目的:先前的研究证实,在接受强度调制放射治疗(IMRT)的前列腺癌患者中,相当大比例的可植入直肠间隔物(IRS)降低了急性胃肠道(GI)毒性。我们根据临床风险因素(CRF)制定了决策规则,以选择那些有望从IRS植入中受益最大的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号